XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 72 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $11,000 | -15.4% | 4,628 | +48.4% | 0.00% | – |
| Q2 2021 | $13,000 | -83.3% | 3,119 | -81.9% | 0.00% | – |
| Q1 2021 | $78,000 | -22.0% | 17,234 | -15.3% | 0.00% | – |
| Q4 2020 | $100,000 | 0.0% | 20,349 | +18.8% | 0.00% | – |
| Q3 2020 | $100,000 | -98.6% | 17,134 | -99.4% | 0.00% | -100.0% |
| Q2 2020 | $7,066,000 | +41464.7% | 2,656,583 | +31084.2% | 0.00% | – |
| Q1 2020 | $17,000 | -72.6% | 8,519 | -2.5% | 0.00% | – |
| Q4 2019 | $62,000 | -27.9% | 8,741 | 0.0% | 0.00% | – |
| Q3 2019 | $86,000 | +8.9% | 8,741 | +19.3% | 0.00% | – |
| Q2 2019 | $79,000 | -16.8% | 7,324 | -22.4% | 0.00% | – |
| Q1 2019 | $95,000 | +227.6% | 9,443 | +452.5% | 0.00% | – |
| Q4 2018 | $29,000 | +7.4% | 1,709 | +11.6% | 0.00% | – |
| Q3 2018 | $27,000 | – | 1,532 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
| DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
| Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
| Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
| Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
| IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
| SEARLE & CO. | 34,000 | $167,000 | 0.08% |
| GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
| ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
| Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |